Sol-Gel Technologies (NASDAQ:SLGL) & Xebra Brands (OTCMKTS:XBRAF) Critical Comparison

Xebra Brands (OTCMKTS:XBRAF) and Sol-Gel Technologies (NASDAQ:SLGL) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Profitability

This table compares Xebra Brands and Sol-Gel Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Xebra Brands	N/A	N/A	N/A
Sol-Gel Technologies	-5.66%	-3.17%	-2.58%

Analyst Ratings

This is a breakdown of current ratings and target prices for Xebra Brands and Sol-Gel Technologies, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Xebra Brands	0	0	0	0	0.00
Sol-Gel Technologies	1	1	3	1	2.67

Sol-Gel Technologies has a consensus price target of $197.50, suggesting a potential upside of 133.20%. Given Sol-Gel Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe Sol-Gel Technologies is more favorable than Xebra Brands.

Earnings & Valuation

This table compares Xebra Brands and Sol-Gel Technologies”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Xebra Brands	N/A	N/A	N/A	N/A	N/A
Sol-Gel Technologies	$19.39 million	12.27	-$6.13 million	($0.34)	-249.09

Xebra Brands has higher earnings, but lower revenue than Sol-Gel Technologies.

Institutional & Insider Ownership

26.2% of Sol-Gel Technologies shares are owned by institutional investors. 66.5% of Sol-Gel Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Sol-Gel Technologies beats Xebra Brands on 7 of the 10 factors compared between the two stocks.

About Xebra Brands

Xebra Brands Ltd. engages in the cultivation, processing, manufacturing, design, and delivery of cannabis products in Canada and Mexico. It provides cannabis infused beverages, including seltzers, soft drinks, iced teas, lemonades, waters, and energy and sport drinks; and wellness products that include capsules, tinctures, topicals, and intimate oils for personal care. The company offers its products under the HighJack, MadCap, Vicious Citrus, Conquer, HolaHi, and HighCastle brands. Xebra Brands Ltd. was incorporated in 2019 and is headquartered in Vancouver, Canada.

About Sol-Gel Technologies

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.